BUZZ-Atrium Therapeutics shares surge after completing $50 million equity financing
路透社2026/10/08 12:01On October 8, shares of heart disease drug developer Atrium Therapeutics (RNA.O) rose 11.3% to $8.83 in pre-market trading on Thursday after the company successfully raised $50 million. The biopharmaceutical company announced it has agreed to sell about 6.3 million shares and pre-funded warrants to institutional investors through a private placement at $7.93 per share. RNA’s shares closed down 0.8% at $7.93 on Wednesday and have fallen roughly 44% in the past month. The company plans to use the net proceeds for the development of its two main product candidates, other research projects, among other uses. Atrium expects that the funds raised, together with existing cash and investments, will be sufficient to support its operations through 2028. Leerink acted as the lead placement agent for this offering, with Cantor Fitzgerald, Barclays, and Wells Fargo participating as well. Based in San Diego, California, Atrium has signed collaboration agreements with Bristol Myers Squibb (BMY.N) and Eli Lilly (LLY.N), and has about 17.1 million shares outstanding. Atrium began public trading on February 27 (link), following a spinoff from Avidity Biosciences (link), which was subsequently acquired by Swiss pharmaceutical company Novartis (NOVN.S).
October 8 - ** Cardiac drug developer Atrium Therapeutics (RNA.O) saw its share price rise 11.3% to $8.83 in pre-market trading on Thursday, after the company successfully completed a $50 million fundraising round.
** The biopharmaceutical company said it had agreed (link) to sell approximately 6.3 million shares of stock and pre-funded warrants to institutional investors via a private placement at $7.93 per share.
** RNA’s share price closed down 0.8% at $7.93 on Wednesday, with a cumulative decline of around 44% over the past month.
** The company plans to use the net proceeds from the fundraising for R&D of its two key candidate products, as well as other research projects and related uses.
** The company expects that the proceeds from this fundraising, together with existing cash and investments, will be sufficient to fund operations through 2028.
** Leerink served as the lead placement agent on this offering, with Cantor Fitzgerald, Barclays, and Wells Fargo participating.
** Based in San Diego, California, Atrium has entered into collaboration agreements with Bristol Myers Squibb BMY.N and Eli Lilly LLY.N, and has about 17.1 million shares outstanding.
** Atrium began public trading on February 27 (link), having been spun off from Avidity Biosciences (link), which has since been acquired by Swiss pharmaceutical company Novartis NOVN.S.
(To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. As automatic translation may contain inaccuracies or lack required context, Reuters does not guarantee the accuracy of the automated translation. Automated translation is provided for reader convenience only. Reuters accepts no liability for any harm or loss arising from the use of the automated translation function.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SpaceX (SPCX.US) completes low-frequency spectrum allocation, targeting the entire US mobile communications market! The three major US telecom stocks plunge collectively after hours
SpaceX has reached an agreement to acquire a nationwide portfolio of low-band spectrum licenses for mobile communications, paving the way for its Starlink Mobile service to directly enter the U.S. telecommunications market.
Apple (AAPL.US) October Second Launch Event Incoming! First Touchscreen MacBook and New iPad mini Unveiled, M6 Chip and Smart Home Ecosystem Released Together
Apple (AAPL.US) is scheduled to launch a comprehensive new smart home strategy next week and plans to hold a second event in October to unveil its first touchscreen MacBook and the new iPad mini.
Pound holds its floor as BoE member Greene presses for a hike
Updated Version 4 - SpaceX Targets U.S. Wireless Operators Through Spectrum Acquisition
The U.S. Federal Communications Commission (FCC) has approved Starlink Mobile Gen2's application to launch 15,000 satellites. Low-frequency radio waves can expand coverage and enhance signal penetration through walls and tree canopies, improving indoor reception. The share prices of T-Mobile, Verizon, and AT&T each fell by nearly 7% in after-hours trading. On October 8, Reuters reported that SpaceX reached an agreement on Thursday to acquire a nationwide portfolio of low-frequency spectrum, enabling Elon Musk's satellite company to directly challenge giant traditional wireless carriers across the United States from orbit. While Starlink Mobile’s existing global 2 GHz mid-band spectrum offers high bandwidth capacity, the new spectrum will allow signal penetration through obstacles. Financial terms of the deal were not disclosed. Low-frequency bands are favored for their longer transmission ranges and ability to penetrate dense structures like walls and tree cover—addressing a major technical challenge previously faced by satellite-based mobile networks. By combining nationwide low-frequency radio coverage with high-frequency space transmission, SpaceX is positioning Starlink Mobile to entirely bypass traditional cell towers, challenging the wireless oligopoly both in wide-area coverage and indoor signal reliability. This deal also increases competitive pressure on traditional operators, shifting direct-to-device satellite technology from a supplementary feature for remote dead spots to a comprehensive commercial rival to terrestrial cellular networks. The share prices of T-Mobile US, Verizon, and AT&T each dropped nearly 7% in after-hours trading. “Incumbent wireless carriers have been publicly skeptical, arguing that SpaceX’s network quality could not match theirs,” said analysts at William Blair. “We expect SpaceX to launch very attractive bundled packages of Starlink broadband with Starlink Mobile, and the company may include Grok in these bundles.” The deal involves acquiring 100% of a nationwide 800 MHz spectrum portfolio from private equity firm Grain Management, pending regulatory approval from the FCC. Earlier this year, Grain had acquired this spectrum from T-Mobile. Crucially, most existing, unmodified mobile phones already support the 800 MHz band, so consumers will not need to purchase special satellite phones. This week, the FCC also approved Starlink Mobile’s application for its second-generation satellite constellation, authorizing SpaceX to launch 15,000 satellites worldwide optimized for the 2 GHz band. This new satellite array will operate in very low Earth orbit, providing regular smartphones with higher bandwidth and low-latency connections.
Crypto prices
More
